Documents

Pharmacogenomic methods – An Epidemiological Perspective

Pharmacogenomics, an important step in the quest for biomarkers of drug response

IMI - current status and future calls

Report from the ENCePP Steering Group

Report from Working Group 1

Report from Working Group 3

Post-authorisation safety studies and the EU PAS Register

New PV Legislation - Reporting

Boosting Drug Development through Public-Private Partnership - The IMI Model